SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-139775
Filing Date
2016-12-15
Accepted
2016-12-15 17:06:05
Documents
38
Period of Report
2016-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v454356_10q.htm 10-Q 369711
2 EXHIBIT 31.1 v454356_ex31-1.htm EX-31.1 9546
3 EXHIBIT 31.2 v454356_ex31-2.htm EX-31.2 9619
4 EXHIBIT 32.1 v454356_ex32-1.htm EX-32.1 4078
5 EXHIBIT 32.2 v454356_ex32-2.htm EX-32.2 4188
  Complete submission text file 0001144204-16-139775.txt   1999310

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT opnt-20161031.xml EX-101.INS 256478
7 XBRL TAXONOMY EXTENSION SCHEMA opnt-20161031.xsd EX-101.SCH 21710
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE opnt-20161031_cal.xml EX-101.CAL 21205
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opnt-20161031_def.xml EX-101.DEF 158774
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE opnt-20161031_lab.xml EX-101.LAB 201286
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opnt-20161031_pre.xml EX-101.PRE 180091
Mailing Address 445 PARK AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address 445 PARK AVENUE 9TH FLOOR NEW YORK NY 10022 212-829-5546
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55330 | Film No.: 162054348
SIC: 1000 Metal Mining